Enjoy a bowl of spicy, saucy ramen topped with marinated steak in this copycat Noodles & Company spicy Korean steak noodles ...

Hims said it would sell a copy of the newly launched weight loss pill for $49, far less than the $149 Novo sells the branded pill for.

Novo Nordisk is suing US telehealth company Hims & Hers to stop it selling “knock-off” versions of its weight-loss drugs, as ...

In his post, Makary said, “FDA will take swift action against companies’ mass-marketing illegal copycat drugs, claiming they ...

Hims & Hers stock fall to a 12-month low after Novo said it's $49 Wegovy pill copy was "illegal" ...

As reality sets in for a football world that predicted the Seattle Seahawks would be a seven-win team this season, the ...

Novo’s shares plunged after telehealth firm Hims & Hers Health Inc. launched a cheaper copycat version of its Wegovy pill.

By Carlos Méndez and Chris Thomas Feb 5 (Reuters) - The U.S. Food and Drug Administration (FDA) will take swift action against companies that mass-market "illegal copycat drugs" by claiming they are ...

Novo Nordisk has sued Hims and Hers Health for patent infringement after the U.S. telehealth firm launched, then canceled, a ...

Hims & Hers says it will stop selling a low-cost copy of a new weight-loss pill made by Novo Nordisk, after federal officials raised concerns that the product may violate drug laws.

Federal officials had warned that the new product from the online provider of weight loss drugs might be illegal.